A new study reveals how the price of treatments for a devastating disease quadrupled over the past decade
In a study published by JAMA Neurology, researchers found that multiple sclerosis patients who have Medicare Part D-government-funded health insurance that covers prescription drug costs-have seen their medication prices quadruple from 2006 to 2016. The rise in drug prices has also translated to an increase in patients’ out-of-pocket expenses, which